Eric J Ende Avadel Pharmaceuticals PLC (AVDL) insider trading activity

AVDL Quotes by TradingView

Eric J Ende is Director of AVADEL PHARMACEUTICALS PLC. Currently has a direct ownership of 178,900 shares of AVDL, which is worth approximately $1.9 Million. The most recent transaction as insider was on Jul 30, 2024, when has been sold 11,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 179K
0% 3M change
6.55% 12M change
Total Value Held $1.9 Million

Eric J Ende Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 30 2024
BUY
Grant, award, or other acquisition
-
11,000 Added 5.79%
178,900 Ordinary Shares
May 18 2023
BUY
Open market or private purchase
$181,090 $13.93 p/Share
13,000 Added 7.19%
167,900 ADSs
Nov 22 2022
BUY
Open market or private purchase
$156,000 $7.8 p/Share
20,000 Added 11.44%
154,900 ADSs
Jun 01 2022
BUY
Open market or private purchase
$45,400 $2.27 p/Share
20,000 Added 12.91%
134,900 ADSs
May 31 2022
BUY
Open market or private purchase
$32,400 $2.16 p/Share
15,000 Added 11.55%
114,900 ADSs
May 27 2022
BUY
Open market or private purchase
$36,750 $2.45 p/Share
15,000 Added 13.05%
99,900 ADSs

Also insider at

MTNB
Matinas BioPharma Holdings, Inc. Healthcare
Director
NBSE
NeuBase Therapeutics, Inc. Healthcare
Director
EJE

Eric J Ende

Director
Dublin 2, L2

Track Institutional and Insider Activities on AVDL

Follow AVADEL PHARMACEUTICALS PLC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVDL shares.

Notify only if

Insider Trading

Get notified when an Avadel Pharmaceuticals PLC insider buys or sells AVDL shares.

Notify only if

News

Receive news related to AVADEL PHARMACEUTICALS PLC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AVDL